Suppr超能文献

使用骨转换标志物对骨质疏松症的治疗与监测

The Treatment and Monitoring of Osteoporosis using Bone Turnover Markers.

作者信息

Patel Nikhil, Ganti Latha

机构信息

Orlando College of Osteopathic Medicine.

Brown University.

出版信息

Orthop Rev (Pavia). 2025 Jan 6;17:127772. doi: 10.52965/001c.127772. eCollection 2025.

Abstract

Osteoporosis is a degenerative bone disease that causes the weakening of bone structure. Since bone structure is dynamic throughout a person's lifespan, bones are under constant growth and destruction in a process known as bone turnover or bone remodeling. Osteoporosis involves the disruption of this growth/destruction equilibrium towards the destructive side. An increase in bone turnover leads to a lower bone density and therefore a greater risk of fracture or injury of higher severity. Bone turnover markers serve as indicators of the process of bone turnover. These markers are split into two groups: formation (building up) markers and resorption (breaking down) markers. Using biochemical techniques and assays, these markers can be measured to monitor the activity of the markers as well as determine treatment options and efficacy based on this activity. The use of biomarkers in osteoporosis can pave the way for their use in other diseases such as cancer.

摘要

骨质疏松症是一种导致骨结构变弱的退行性骨病。由于骨结构在人的一生中是动态变化的,骨骼在一个被称为骨转换或骨重塑的过程中不断生长和破坏。骨质疏松症涉及这种生长/破坏平衡向破坏一侧的失调。骨转换增加会导致骨密度降低,因此骨折或更严重损伤的风险更大。骨转换标志物是骨转换过程的指标。这些标志物分为两组:形成(构建)标志物和吸收(分解)标志物。使用生化技术和检测方法,可以测量这些标志物,以监测标志物的活性,并根据这种活性确定治疗方案和疗效。骨质疏松症中生物标志物的使用可为其在癌症等其他疾病中的应用铺平道路。

相似文献

2
Current use of bone turnover markers in the management of osteoporosis.骨转换标志物在骨质疏松症管理中的当前应用。
Clin Biochem. 2022 Nov-Dec;109-110:1-10. doi: 10.1016/j.clinbiochem.2022.09.002. Epub 2022 Sep 9.
8
Use of bone turnover markers in postmenopausal osteoporosis.绝经后骨质疏松症中骨转换标志物的应用。
Lancet Diabetes Endocrinol. 2017 Nov;5(11):908-923. doi: 10.1016/S2213-8587(17)30184-5. Epub 2017 Jul 7.
9
Use of bone turnover markers in the management of osteoporosis.骨转换标志物在骨质疏松症管理中的应用。
Curr Opin Endocrinol Diabetes Obes. 2018 Dec;25(6):366-372. doi: 10.1097/MED.0000000000000446.

本文引用的文献

1
Nutrition and Osteoporosis Prevention.营养与骨质疏松预防
Curr Osteoporos Rep. 2024 Dec;22(6):515-522. doi: 10.1007/s11914-024-00892-0. Epub 2024 Sep 25.
4
Osteoblast-osteoclast interactions.成骨细胞-破骨细胞相互作用。
Connect Tissue Res. 2018 Mar;59(2):99-107. doi: 10.1080/03008207.2017.1290085. Epub 2017 Mar 21.
5
An overview and management of osteoporosis.骨质疏松症概述与管理
Eur J Rheumatol. 2017 Mar;4(1):46-56. doi: 10.5152/eurjrheum.2016.048. Epub 2016 Dec 30.
7
Biochemical markers of bone turnover - uses and limitations.骨转换生化标志物——用途和局限性。
Ann Clin Biochem. 2014 Mar;51(Pt 2):189-202. doi: 10.1177/0004563213515190. Epub 2014 Jan 7.
10
A comparison of the urinary excretion of bone resorptive products in white and black children.
J Lab Clin Med. 1996 Jan;127(1):67-70. doi: 10.1016/s0022-2143(96)90167-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验